Subsequently, in vitro assays conducted in an ESCC-derived cell line clearly showed that FOXM1 binds onto UBE2C promoter region and that FOXM1 induced expression resulted in both increased luciferase activity driven by UBE2C-promoter and increased levels of UBE2C protein. Here, UBE2C is linked to esophageal squamous cell carcinoma.